MaytaSep 245 min readLDL and Cholesterol Goals in Patients with Type 2 Diabetes and Cardiovascular Risk [LDL in ACS, LDL in ASCVD]
MaytaSep 239 min readGlucose-lowering Therapy in Patients with Type 2 Diabetes and Atherosclerotic Cardiovascular Disease (ASCVD)
MaytaSep 235 min readDiabetes Mellitus (DM) Diagnosis and Management [Metformin, Sulfonylureas: Glimepiride, DPP-4 inhibitors: Sitagliptin, SGLT-2 inhibitors: Empagliflozin, GLP-1 receptor agonists: Liraglutide]
![LDL and Cholesterol Goals in Patients with Type 2 Diabetes and Cardiovascular Risk [LDL in ACS, LDL in ASCVD]](https://static.wixstatic.com/media/0cd34d_46edbc86fcd94f17bf5a95216e71fb27~mv2.png/v1/fill/w_654,h_654,fp_0.50_0.50,q_95,enc_auto/0cd34d_46edbc86fcd94f17bf5a95216e71fb27~mv2.png)
![Diabetes Mellitus (DM) Diagnosis and Management [Metformin, Sulfonylureas: Glimepiride, DPP-4 inhibitors: Sitagliptin, SGLT-2 inhibitors: Empagliflozin, GLP-1 receptor agonists: Liraglutide]](https://static.wixstatic.com/media/0cd34d_4df5953e0d61421d988631e1e0629da3~mv2.png/v1/fill/w_837,h_837,fp_0.50_0.50,q_95,enc_auto/0cd34d_4df5953e0d61421d988631e1e0629da3~mv2.png)